Publication | Closed Access

Pembrolizumab for previously treated, microsatellite instability–high/mismatch repair–deficient advanced colorectal cancer: final analysis of KEYNOTE-164

Microsatellite Instability–high/mismatch Repair–deficientMedicineImmunologyColorectal CancerPathologyImmune Checkpoint InhibitorCancer GeneticsMolecular DiagnosticsOncologyRadiation OncologyMolecular OncologyFinal Analysis